Home Authors Posts by staff

staff

62 POSTS 0 COMMENTS

The PGT Healthcare partnership at an end

AstraZeneca licensed rights for Seroquel

Human-centered design to improve management of cancer symptoms

A research accelerator for AbbVie

Gsk to transfer its portfolio of rare disease gene therapies

Subcutaneous therapy for chronic inflammatory demyelinating polyneuropathy

Green light to gemtuzumab ozogamicin for acute myeloid leukemia

Gene therapy for transfusion-dependent β-thalassemia

Positive top-line data from the STORM study on selinexor in patients...

Results of Phase 2a trial on safeproxalap for dry eye disease

1...567Page 6 of 7

Newsstand

  • Supplemento to n.9 - October 2024 NCF International n.3 - 2024
  • NCF International n.2 - 2024
  • Supplemento to n.1 - January 2024 NCF International n.1 - 2024
Newsstand
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151